Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List

Molecular Predictors of Pemetrexed and Carboplatin Response in Tumor Samples of a Series of Malignant Pleural Mesothelioma (MPM) Patients and Genotyping for the TSER Polymorphism

Conditions: Malignant Pleural Mesothelioma
Start Date: January 1, 2009
Phase:
Status: Active, not recruiting
NCT ID: NCT00867711
Study Type: Observational
Intervention:
Study Design: Observational Model: Cohort|Time Perspective: Retrospective
Results: No Results Available
Sponsors: Istituto Clinico Humanitas
Ages: Adult|Senior
Enrollment: 100
Funded By: Other
First Received: March 23, 2009
End Date: September 1, 2009
Last Updated: September 1, 2010
Last Verified: September 1, 2010

Mesothelioma
Lawsuit Evaluation

First Name
Last Name
Phone Number
Email
Zip Code
Details:
Please Include Diagnosis Date
Type The Number Below: